Browse All

Current Filters

CLEAR FILTER x

TITLE

Exploring Triple Overlap Syndrome in Patients Receiving Immune Checkpoint Inhibitors: A Case Series Analysis

Author:Boldig, Catherine   Martinez Salazar, Armando   Hong, Luke   Peguero, Edwin   Jaffer, Muhammad   Mokhtari, Sepideh   

Session Name:P8: Autoimmune Neurology: Immune Therapy Complications, Neurorheumatology, and Other Inflammatory Disorders  

Topic:Autoimmune Neurology  

Program Number:P8.001  

Author Institution:University of South Florida Morsani College of Medicine, Brandon, FL  

Exploring Ultrastructural Pathology in Gliomas: Insights from Recent Studies

Author:Sulman, Muhammad   Aboud, Orwa   

Session Name:P4: Neuro-oncology: Molecular Neuro-oncology  

Topic:Neuro-oncology  

Program Number:P4.018  

Author Institution:University of California, Davis, Sacramento, CA  

Expression Patterns of Killer Cell Immunoglobulin-like Receptors in Natural Killer and Natural Killer T Cells Across Neuroinflammatory Diseases

Author:Mikami, Takahisa   Nishiyama, Shuhei   Levy, Michael   

Session Name:P1: Autoimmune Neurology: Biomarkers  

Topic:Autoimmune Neurology  

Program Number:P1.011  

Author Institution:Massachusetts General Hospital, Cambridge, MA  Tohoku University Graduate school of Medicine, Sendai, Japan  Massachusetts General Hospital/Harvard Medical School, Boston, MA  

Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital

Author:Nasir, Moneeb   Athukoralage, Kasun   Rabvukwa, Plaxedes   Fuller, Sarah   Azzopardi, Laura   Chaudhuri, Abhijit   Mattoscio, Miriam   

Session Name:P12: Multiple Sclerosis: Clinical and Translational Research in MS 2  

Topic:Multiple Sclerosis  

Program Number:P12.009  

Author Institution:The Royal London Hospital, London, United Kingdom  Queen’s Hospital, Romford, United Kingdom  

Extension Study MT-1186-A04 Evaluating Oral Edaravone (Radicava ORS®) Continued Efficacy and Safety up to an Additional 48 Weeks in Patients With ALS

Author:Genge, Angela   Rothstein, Jeffrey   De Silva, Shari   Zinman, Lorne   Chum, Marvin   Chio, Adriano   Sobue, Gen   Doyu, Manabu   Selness, Daniel   Todorovic, Vesna   Sasson, Nissim   Takahashi, Fumihiro   Cecic, Michelle   Wamil, Art   Apple, Stephen   

Session Name:P9: General Neurology: Motor Neuron Disease 2  

Topic:General Neurology  

Program Number:P9.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD  Woodland Research Northwest, Rogers, AR  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  McMaster University Health Sciences Centre, Hamilton, ON, Canada  Università degli Studi di Torino, Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica (CRESLA), Torino, Italy  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Japan  Department of Neurology, Aichi Medical University, Nagakute, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe, Ltd., London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel